Stay updated on ISB 830 Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check14 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check50 days agoChange DetectedThe page has been updated to reflect a new version of the study on ISB 830 for moderate to severe atopic dermatitis, with changes in the revision number and the removal of detailed study descriptions and inclusion/exclusion criteria.SummaryDifference7%
- Check57 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to ISB 830 Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page.